marcus evans north america conferences

Commercialization and Portfolio Optimization for Pharma

Developing Comprehensive Commercialization Plans to Ensure Successful Product Launch

14-15 Aug 2019
Philadelphia, United States of America

Conference Workshop

Maximizing Market Access in order to Amplify the Path into a Successful Launch

Conference Workshop

Determining Different Considerations when Initiating Launch Preparedness to Benefit a New Product Going into Market with Astellas Pharma


Why You Should Attend

Commercialization and Portfolio Optimization for Pharma

This premier marcus evans event will bring together the foremost leaders within the commercial strategy and product launch divisions to identify strategies to strengthen cross-functional collaboration, portfolio prioritization, and data analytics for robust commercialization planning. Attendees will leave with new insights and tactics for overcoming barriers related to market access and pricing.

Introducing a new drug to market is one of the greatest risks that pharmaceutical and biotechnology manufacturers face. The ability to develop a comprehensive commercialization strategy is vital in order to achieve a successful product launch. Managing a new drug within the overall portfolio is also a common challenge those in the space are trying to overcome to better implement commercial insight earlier.

Key Topics

  • Optimize market access to include endpoints that are meaningful to both payers and patients
  • Enhance commercialization strategy in order to ensure a successful product launch
  • Implement cross-functional collaboration to eliminate silos between stakeholder groups
  • Maximize data analytics to gain beneficial insights for a successful commercialization plan
  • Integrate commercial input earlier in development to reduce the risk of missing crucial information
  • Previous Attendees Include

    Amgen,
    Astra Zeneca,
    Biogen,
    Boehringer Ingelheim,
    Bristol-Myers Squibb Company,
    Cora Systems,
    CSL Behring,
    Curium Pharmaceuticals,
    Daiichi Sankyo,
    Ferring,
    Halozyme Therapeutics,
    Innovate Biopharmaceuticals,
    Intarcia Therapeutics,
    Janssen Supply Group,
    Jazz Pharmaceuticals,
    Johnson & Johnson,
    Kite Pharma,
    Mallinckrodt Pharmaceuticals,
    Medimmune,
    Merck Animal Health,
    Nevakar,
    Pfizer,
    Sandoz,
    Takeda Pharmaceuticals,
    Teva Pharmaceuticals


    Why Choose marcus evans?

    marcus evans specialises in the research and development of strategic events for senior business executives. From our international network of 63 offices, marcus evans produces over 1000 event days a year on strategic issues in corporate finance, telecommunications, technology, health, transportation, capital markets, human resources and business improvement.

    Above all, marcus evans provides clients with business information and knowledge which enables them to sustain a valuable competitive advantage and makes a positive contribution to their success.




    Event Partners


    Practical Insights From

    Divya Yerraguntla
    Senior Director, Head Global Commercial PMO
    Sun Pharmaceutical Industries, Inc.

    Michele Mencer
    Head, Commercial Operations Neuroscience Franchise, US Pharma
    Novartis

    Michael Januszeski, PhD MBA
    Global Commercial Strategy Director
    Janssen, Pharmaceutical Companies of Johnson and Johnson

    Joseph Bonaccorso
    Chief Commercial Officer
    Verrica Pharmaceuticals

    Nicolas Rivelis
    Assistant Director Launch Excellence
    Astellas Pharma

    Liam Moy
    Director Patient Support Services
    Sage Therapeutics

    Sasha Zbitnoff
    Associate Director, Commercial Project Management
    Alkermes

    Kara Reheis
    VP Commercial Operations
    Daiichi Sankyo

    Click Here For Full Agenda

    Voice of Our Customers
    • “Overall great use of two days. I learned many nuanced points on topics I already felt I had a good handle on. New information!” -Medtronic
    • “Good opportunity to hear a diverse set of perspectives on a common topic. I value the insightful comments and ideas.” -Celgene
    • “This is a very informative conference; this was well organized – credit goes to the organizers.” -Alcon Novartis
    • “Great presentations and several opportunities to network. Stellar meeting logistics and support.” -Amgen
    Latest Conference News & Resources



    Join the Discussion

    Follow on LinkedIn





    Event Contact

    For all enquiries regarding speaking, sponsoring and attending this conference contact:

    Melini Hadjitheori


    PO Box 24797
    CY-1304 Nicosia


    Telephone:
    +357 22 849 308
    Fax: +357 22 849 394
    Email: MeliniH@marcusevanscy.com